has 30 years experience in the medical products and biotechnology fields.
In general management roles as CEO or senior executive in commercial and development stage organizations, both public and private, he
has been instrumental in the successful growth and development of several prominent companies.
has been responsible for global commercial operations including new product launches, corporate development, and research and development.
also has extensive financing and board director experience.
Prior to founding Red Sky partners in early 2009, Greg held positions of Chairman and CEO of RenaMed Biologics, Vice Chairman of Dyax Corporation, Executive Vice President of Genzyme Corporation, Vice President of Baxter Travenol Laboratories, and CEO of Ardais, Viagene, and ZymoGenetics.
He has served on the Board of Directors of ten public and private healthcare companies and two non-profit organizations and presently serves as Chairman of the Board of Proteon Therapeutics, Inc.
Greg received a B.S. in Electrical Engineering from Bradley University and an MBA from Harvard Business School.
photo: Greg Phelps